Unmasking the impact of cytomegalovirus reactivation in people with advanced HIV disease with <i>Pneumocystis Jirovecii</i> pneumonia: does antiviral therapy change outcomes?
CMV DNA detection in people with HIV hospitalized with PJP was associated with worse outcomes. Anti-CMV therapy was more often used in severe cases and showed an association with in-hospital mortality in unadjusted analyses. The observational design precludes determination of causality.
Authors
- Dita Smíšková (ORCID: https://orcid.org/0000-0001-5699-6474)
- H Rozsypal
- D Veselý
- Marek Ďuríček (ORCID: https://orcid.org/0009-0006-6449-0434)
- Kryštof Šram
- David Jilich
Institutions
- Charles University (CZ)
Publication Details
- Journal
- HIV Research & Clinical Practice
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1080/25787489.2026.2621466
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00